TELK

Telik Inc

Clinical-stage biopharmaceutical company developing small molecule oncology drugs

2007 Q44 of 5 quarters

Total Value

$3.61M

Total Shares

1.04M

Net Share Change

+1.04M

Activity

1 buying

Investor

Value

Shares

Weight

Change

Icahn Capital LP

$3.61M

1.04M

0.0%

NEW

Major holders (13D/G) →